James New

James New is the founder of Wavodyne Therapeutics, Inc. Former positions include Chief Executive Officer at Abrika Pharmaceuticals LLP from 2002 to 2007, President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2008 to 2009, Chief Executive Officer at AIKO Biotechnology, Inc., President & Chief Executive Officer at Synaptogenix, Inc. in 2014, Director at Neurotrope, Inc. in 2014, Principal at Bristol Myers Squibb Co. from 1980 to 1992, Principal at Pfizer Inc. from 1994 to 1999, Principal at Novartis AG from 1999 to 2001, and Principal at GSK Plc.
Education includes an undergraduate degree from State University of New York College at Geneseo, a doctorate from State University of New York at Buffalo, a graduate degree from the University of Maine, and an MBA from Columbia Business School.